SONOMA PHARMACEUTICALS, INC. Amortization of Debt Discount (Premium)
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Amortization of Debt Discount (Premium) of $0 for the 12-month period ending 2013-03-31, per its 10-K filed 2013-06-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2013-06-25
- SONOMA PHARMACEUTICALS, INC. amortization of debt discount (premium) for the quarter ending 2012-03-31 was $0.00.
- SONOMA PHARMACEUTICALS, INC. amortization of debt discount (premium) for the quarter ending 2011-12-31 was $156.00K, a 37.60% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. amortization of debt discount (premium) for the quarter ending 2011-09-30 was $156.00K.
- SONOMA PHARMACEUTICALS, INC. amortization of debt discount (premium) for the quarter ending 2011-06-30 was $938.00K, a 87.60% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. amortization of debt discount (premium) for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- SONOMA PHARMACEUTICALS, INC. amortization of debt discount (premium) for fiscal 2012 was $1.25M, a 66.67% increase from fiscal 2011.
- SONOMA PHARMACEUTICALS, INC. amortization of debt discount (premium) for fiscal 2011 was $750.00K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2013-03-31 | $0.00 10-K · filed 2013-06-25 | |||
| 2012-09-30 | $0.00 10-Q · filed 2012-11-08 | |||
| 2012-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-25 | $156.00K derived: sum of 2 quarters · filed 2013-06-25 | $312.00K derived: sum of 3 quarters · filed 2013-06-25 | $1.25M 10-K · filed 2013-06-25 |
| 2011-12-31 | $156.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-13 | $312.00K derived: sum of 2 quarters · filed 2013-02-13 | $1.25M 10-Q · filed 2013-02-13 | $1.25M derived: sum of 4 quarters · filed 2013-02-13 |
| 2011-09-30 | $156.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-11-08 | $1.09M 10-Q · filed 2012-11-08 | $1.09M derived: sum of 3 quarters · filed 2012-11-08 | $1.34M derived: sum of 4 quarters · filed 2012-11-08 |
| 2011-06-30 | $938.00K 10-Q/A · filed 2012-08-31 | $938.00K derived: sum of 2 quarters · filed 2012-08-31 | $1.19M derived: sum of 3 quarters · filed 2012-08-31 | $1.19M derived: sum of 4 quarters · filed 2012-08-31 |
| 2011-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-06-21 | $250.00K derived: sum of 2 quarters · filed 2012-06-21 | $250.00K derived: sum of 3 quarters · filed 2012-06-21 | $750.00K 10-K · filed 2012-06-21 |
| 2010-12-31 | $250.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-10 | $250.00K derived: sum of 2 quarters · filed 2012-02-10 | $750.00K 10-Q · filed 2012-02-10 | |
| 2010-09-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2011-11-03 | $500.00K 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | $500.00K 10-Q/A · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |